Beijing Beilu Pharmaceutical Co., Ltd
SHZ: 300016.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xu Wang
- Employees
- 1,173
- Headquarters
- Beijing, China
- IPO year
- 2009
- Market cap
- CN¥5.4B
- Website
- https://www.beilu.com.cn
Loading 300016…
Loading profile data…Frequently asked questions about 300016
What does Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) do?
Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.
Where does 300016.SZ trade?
Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300016.SZ in?
Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Beijing Beilu Pharmaceutical Co., Ltd?
Xu Wang is the chief executive officer of Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ).
Where is Beijing Beilu Pharmaceutical Co., Ltd headquartered?
Beijing Beilu Pharmaceutical Co., Ltd is headquartered in China.
Does 300016.SZ pay a dividend?
Yes — Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300016.SZ go public?
Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) completed its initial public offering in 2009.